Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
27.3M
-
Number of holders
-
82
-
Total 13F shares, excl. options
-
22.9M
-
Shares change
-
+3.07M
-
Total reported value, excl. options
-
$265M
-
Value change
-
+$37M
-
Put/Call ratio
-
0.69
-
Number of buys
-
54
-
Number of sells
-
-14
-
Price
-
$11.44
Significant Holders of Alto Neuroscience, Inc. - Common Stock, $0.0001 par value per share (ANRO) as of Q3 2024
90 filings reported holding ANRO - Alto Neuroscience, Inc. - Common Stock, $0.0001 par value per share as of Q3 2024.
Alto Neuroscience, Inc. - Common Stock, $0.0001 par value per share (ANRO) has 82 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.9M shares
of 27.3M outstanding shares and own 84.18% of the company stock.
Largest 10 shareholders include Alpha Wave Global, LP (3.71M shares), FMR LLC (2.36M shares), RA CAPITAL MANAGEMENT, L.P. (2.08M shares), BlackRock, Inc. (1.45M shares), VANGUARD GROUP INC (1.27M shares), FRANKLIN RESOURCES INC (1.22M shares), ExodusPoint Capital Management, LP (1.16M shares), Point72 Asset Management, L.P. (978K shares), ALKEON CAPITAL MANAGEMENT LLC (935K shares), and JENNISON ASSOCIATES LLC (832K shares).
This table shows the top 82 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.